FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:314-319 February 3, 2000 Number 5 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures.

Methods We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year.

Results Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent).

Conclusions Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.

Source Information

From the Epilepsy Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.

Address reprint requests to Dr. Brodie at the Epilepsy Unit, Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, Scotland, or at martin.j.brodie{at}clinmed.gla.ac.uk.

Full Text of this Article

This article has been cited by other articles:

• Noe, F., Pool, A.-H., Nissinen, J., Gobbi, M., Bland, R., Rizzi, M., Balducci, C., Ferraguti, F., Sperk, G., During, M. J., Pitkanen, A., Vezzani, A. (2008). Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 0: awn079v1-awn079 [Abstract] [Full Text]  
• Ludanyi, A., Eross, L., Czirjak, S., Vajda, J., Halasz, P., Watanabe, M., Palkovits, M., Magloczky, Z., Freund, T. F., Katona, I. (2008). Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus. J. Neurosci. 28: 2976-2990 [Abstract] [Full Text]  
• Holmes, G. L. (2007). Animal model studies application to human patients. Neurology 69: S28-S32 [Abstract] [Full Text]  
• Cascino, G. D. (2007). Improving quality of life with epilepsy surgery: The seizure outcome is the key to success. Neurology 68: 1967-1968 [Full Text]  
• Pellock, J. M. (2007). Overview: Definitions and Classifications of Seizure Emergencies. J Child Neurol 22: 9S-13S [Abstract]  
• Pellock, J. M., Shinnar, S. (2007). Conclusion: Having a Plan to Manage Seizure Emergencies. J Child Neurol 22: 71S-73S  
• Loacker, S., Sayyah, M., Wittmann, W., Herzog, H., Schwarzer, C. (2007). Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain 130: 1017-1028 [Abstract] [Full Text]  
• Gaillard, W. D., Weinstein, S., Conry, J., Pearl, P. L., Fazilat, S., Fazilat, S., Vezina, L. G., Reeves-Tyer, P., Theodore, W. H. (2007). Prognosis of children with partial epilepsy: MRI and serial 18FDG-PET. Neurology 68: 655-659 [Abstract] [Full Text]  
• Brodie, M. J., Perucca, E., Ryvlin, P., Ben-Menachem, E., Meencke, H.-J, for the Levetiracetam Monotherapy Study Group, (2007). Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68: 402-408 [Abstract] [Full Text]  
• Chen, C.-C., Chiu, P.-C., Chen, M.-T. (2007). Reinvestigation and Reduction of Polytherapy in Children With Chronic Seizures. J Child Neurol 22: 15-20 [Abstract]  
• Spooner, C. G., Berkovic, S. F., Mitchell, L. A., Wrennall, J. A., Harvey, A. S. (2006). New-onset temporal lobe epilepsy in children: Lesion on MRI predicts poor seizure outcome. Neurology 67: 2147-2153 [Abstract] [Full Text]  
• Shafique, S., Dalsing, M. C. (2006). Vagus Nerve Stimulation Therapy for Treatment of Drug-Resistant Epilepsy and Depression. PERSPECT VASC SURG ENDOVASC THER 18: 323-327 [Abstract]  
• McGregor, A., Wheless, J. (2006). Pediatric Experience With Sudden Unexplained Death in Epilepsy at a Tertiary Epilepsy Center. J Child Neurol 21: 782-787 [Abstract]  
• Artama, M., Isojarvi, J.I.T., Auvinen, A. (2006). Antiepileptic drug use and birth rate in patients with epilepsy--a population-based cohort study in Finland. Hum Reprod 21: 2290-2295 [Abstract] [Full Text]  
• Khosravani, H., Zamponi, G. W. (2006). Voltage-gated calcium channels and idiopathic generalized epilepsies.. Physiol. Rev. 86: 941-966 [Abstract] [Full Text]  
• Glauser, T. A., Ayala, R., Elterman, R. D., Mitchell, W. G., Van Orman, C. B., Gauer, L. J., Lu, Z., on behalf of the N159 Study Group, (2006). Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66: 1654-1660 [Abstract] [Full Text]  
• Reynolds, E. (2006). Treating refractory epilepsy in adults. BMJ 332: 562-563 [Full Text]  
• Sillanpaa, M., Schmidt, D. (2006). Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 129: 617-624 [Abstract] [Full Text]  
• Thivard, L., Adam, C., Hasboun, D., Clemenceau, S., Dezamis, E., Lehericy, S., Dormont, D., Chiras, J., Baulac, M., Dupont, S. (2006). Interictal diffusion MRI in partial epilepsies explored with intracerebral electrodes. Brain 129: 375-385 [Abstract] [Full Text]  
• Remy, S., Beck, H. (2006). Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129: 18-35 [Abstract] [Full Text]  
• Oskoui, M., Webster, R. I., Xun Zhang, , Shevell, M. I. (2005). Factors Predictive of Outcome in Childhood Epilepsy. J Child Neurol 20: 898-904 [Abstract]  
• Hawkins, N., Epstein, D., Drummond, M., Wilby, J., Kainth, A., Chadwick, D., Sculpher, M. (2005). Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model. Med Decis Making 25: 493-510 [Abstract]  
• Hildebrand, J., Lecaille, C., Perennes, J., Delattre, J.-Y. (2005). Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65: 212-215 [Abstract] [Full Text]  
• Volk, H. A., Loscher, W. (2005). Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128: 1358-1368 [Abstract] [Full Text]  
• Burneo, J. G., McLachlan, R. S. (2005). When should surgery be considered for the treatment of epilepsy?. CMAJ 172: 1175-1177 [Full Text]  
• Kelso, A. R. C., Cock, H. R. (2005). Advances in epilepsy. Br Med Bull 72: 135-148 [Abstract] [Full Text]  
• Gilliam, F., Carter, J., Vahle, V. (2004). Tolerability of antiseizure medications: Implications for health outcomes. Neurology 63: S9-S12 [Abstract] [Full Text]  
• Sankar, R. (2004). Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues. Neurology 63: S30-S39 [Abstract] [Full Text]  
• Kwan, P, Sander, J W (2004). The natural history of epilepsy: an epidemiological view. J. Neurol. Neurosurg. Psychiatry 75: 1376-1381 [Abstract] [Full Text]  
• Beyenburg, S, Bauer, J, Reuber, M (2004). New drugs for the treatment of epilepsy: a practical approach. Postgrad. Med. J. 80: 581-587 [Abstract] [Full Text]  
• Vazquez, B. (2004). Monotherapy in Epilepsy: Role of the Newer Antiepileptic Drugs. Arch Neurol 61: 1361-1365 [Abstract] [Full Text]  
• Timofeev, I., Grenier, F., Steriade, M. (2004). Contribution of Intrinsic Neuronal Factors in the Generation of Cortically Driven Electrographic Seizures. J. Neurophysiol. 92: 1133-1143 [Abstract] [Full Text]  
• Arts, W. F. M., Brouwer, O. F., Peters, A. C. B., Stroink, H., Peeters, E. A. J., Schmitz, P. I. M., van Donselaar, C. A., Geerts, A. T. (2004). Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain 127: 1774-1784 [Abstract] [Full Text]  
• French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., Bergen, D., Hirtz, D., Montouris, G. D., Nespeca, M., Gidal, B., Marks, W. J. Jr., Turk, W. R., Fischer, J. H., Bourgeois, B., Wilner, A., Faught, R. E. Jr., Sachdeo, R. C., Beydoun, A., Glauser, T. A. (2004). Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62: 1252-1260 [Abstract] [Full Text]  
• LaRoche, S. M., Helmers, S. L. (2004). The New Antiepileptic Drugs: Scientific Review. JAMA 291: 605-614 [Abstract] [Full Text]  
• Helmstaedter, C, Van Roost, D, Clusmann, H, Urbach, H, Elger, C E, Schramm, J (2004). Collateral brain damage, a potential source of cognitive impairment after selective surgery for control of mesial temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry 75: 323-326 [Abstract] [Full Text]  
• Khan, R. B., Hunt, D. L., Thompson, S. J. (2004). Gabapentin to Control Seizures in Children Undergoing Cancer Treatment. J Child Neurol 19: 97-101 [Abstract]  
• Tatum, W. O. IV, Liporace, J., Benbadis, S. R., Kaplan, P. W. (2004). Updates on the Treatment of Epilepsy in Women. Arch Intern Med 164: 137-145 [Abstract] [Full Text]  
• Nicolson, A, Appleton, R E, Chadwick, D W, Smith, D F (2004). The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J. Neurol. Neurosurg. Psychiatry 75: 75-79 [Abstract] [Full Text]  
• Christensen, J., Andreasen, F., Poulsen, J. H., Dam, M. (2003). Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology 61: 1210-1218 [Abstract] [Full Text]  
• van Drongelen, W., Koch, H., Marcuccilli, C., Pena, F., Ramirez, J.-M. (2003). Synchrony Levels During Evoked Seizure-Like Bursts in Mouse Neocortical Slices. J. Neurophysiol. 90: 1571-1580 [Abstract] [Full Text]  
• Trevathan, E., Gilliam, F. (2003). Lost years: Delayed referral for surgically treatable epilepsy. Neurology 61: 432-433 [Full Text]  
• Devinsky, O. (2003). A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness. JAMA 290: 381-392 [Full Text]  
• Kwan, P., Brodie, M. J. (2003). Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 60: S2-12 [Abstract] [Full Text]  
• Murphy, J. V., Torkelson, R., Dowler, I., Simon, S., Hudson, S. (2003). Vagal Nerve Stimulation in Refractory Epilepsy: The First 100 Patients Receiving Vagal Nerve Stimulation at a Pediatric Epilepsy Center. Arch Pediatr Adolesc Med 157: 560-564 [Abstract] [Full Text]  
• Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R., Brooks, D. J., Duncan, J. S. (2003). Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 126: 1300-1318 [Abstract] [Full Text]  
• ANDREWS, R. J. (2003). Neuroprotection Trek--The Next Generation: Neuromodulation I. Techniques--Deep Brain Stimulation, Vagus Nerve Stimulation, and Transcranial Magnetic Stimulation. Ann. N. Y. Acad. Sci. 993: 1-13 [Abstract] [Full Text]  
• Camfield, P., Camfield, C. (2003). Childhood Epilepsy: What Is the Evidence for What We Think and What We Do?. J Child Neurol 18: 272-287 [Abstract]  
• Engel, J. Jr., Wiebe, S., French, J., Sperling, M., Williamson, P., Spencer, D., Gumnit, R., Zahn, C., Westbrook, E., Enos, B. (2003). Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 60: 538-547 [Abstract] [Full Text]  
• Brodie, M. J., Leach, J. P. (2003). Success or failure with antiepileptic drug therapy: Beyond empiricism?. Neurology 60: 162-163 [Full Text]  
• Gilliam, F.G., Veloso, F., Bomhof, M.A.M., Gazda, S.K., Biton, V., Ter Bruggen, J.P., Neto, W., Bailey, C., Pledger, G., Wu, S.-C. (2003). A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 60: 196-202 [Abstract] [Full Text]  
• von Oertzen, J, Urbach, H, Jungbluth, S, Kurthen, M, Reuber, M, Fernandez, G, Elger, C E (2002). Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J. Neurol. Neurosurg. Psychiatry 73: 643-647 [Abstract] [Full Text]  
• Chawla, J., Sucholeiki, R., Jones, C., Silver, K. (2002). Intractable Epilepsy With Ring Chromosome 20 Syndrome Treated With Vagal Nerve Stimulation: Case Report and Review of the Literature. J Child Neurol 17: 778-780 [Abstract]  
• Schachter, S. C., Wheless, J. W. (2002). The evolving place of vagus nerve stimulation therapy. Neurology 59: S1-2 [Abstract] [Full Text]  
• Wheless, J. W., Maggio, V. (2002). Vagus nerve stimulation therapy in patients younger than 18 years. Neurology 59: S21-25 [Abstract] [Full Text]  
• Renfroe, J. B., Wheless, J. W. (2002). Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology 59: S26-30 [Abstract] [Full Text]  
• Walker, M. C., White, H. S., Sander, J. W. A. S. (2002). Disease modification in partial epilepsy. Brain 125: 1937-1950 [Abstract] [Full Text]  
• Holmes, G. (2002). Epilepsy surgery in children: When, why, and how. Neurology 58: S13-S20 [Full Text]  
• Diaz-Arrastia, R., Agostini, M. A., Van Ness, P. C. (2002). Evolving Treatment Strategies for Epilepsy. JAMA 287: 2917-2920 [Full Text]  
• Brodie, M. J., Kwan, P. (2002). Staged approach to epilepsy management. Neurology 58: S2-8 [Abstract] [Full Text]  
• Gilliam, F. (2002). Optimizing health outcomes in active epilepsy. Neurology 58: S9-20 [Abstract] [Full Text]  
• Meador, K. J. (2002). Cognitive outcomes and predictive factors in epilepsy. Neurology 58: S21-26 [Abstract] [Full Text]  
• Wiebe, S., Nicolle, M. W (2002). Recent developments: Recent developments in neurology. BMJ 324: 656-660 [Full Text]  
• Dlugos, D. J., Sammel, M. D., Strom, B. L., Farrar, J. T. (2001). Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57: 2259-2264 [Abstract] [Full Text]  
• Krauss, G. L., Ampaw, L., Krumholz, A. (2001). Individual state driving restrictions for people with epilepsy in the US. Neurology 57: 1780-1785 [Abstract] [Full Text]  
• Dlugos, D. J. (2001). The Early Identification of Candidates for Epilepsy Surgery. Arch Neurol 58: 1543-1546 [Abstract] [Full Text]  
• Hemingway, C., Freeman, J. M., Pillas, D. J., Pyzik, P. L. (2001). The Ketogenic Diet: A 3- to 6-Year Follow-Up of 150 Children Enrolled Prospectively. Pediatrics 108: 898-905 [Abstract] [Full Text]  
• Wiebe, S., Blume, W. T., Girvin, J. P., Eliasziw, M., the Effectiveness and Efficiency of Surgery for Te, (2001). A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy. NEJM 345: 311-318 [Abstract] [Full Text]  
• Engel, J. Jr. (2001). Finally, a Randomized, Controlled Trial of Epilepsy Surgery. NEJM 345: 365-367 [Full Text]  
• McCabe, P. H., McNew, C. D., Michel, N. C. (2001). Effect of Divalproex-Lamotrigine Combination Therapy in Frontal Lobe Seizures. Arch Neurol 58: 1264-1268 [Abstract] [Full Text]  
• Holmes, G. L., Engel, J. Jr (2001). Predicting medical intractability of epilepsy in children: How certain can we be?. Neurology 56: 1430-1431 [Full Text]  
• Benbadis, S. R., Tatum, W. O., Vale, a. F. L. (2000). When drugs don't work: An algorithmic approach to medically intractable epilepsy. Neurology 55: 1780-1784 [Abstract] [Full Text]  
• (2000). {blacktriangledown}Tiagabine: add-on treatment for partial seizures. DTB 38: 47-48 [Abstract] [Full Text]  
• (2000). Refractory Epilepsy Declares Itself Early. JWatch Neurology 2000: 2-2 [Full Text]  
• (2000). Predictors of Refractory Epilepsy. JWatch General 2000: 7-7 [Full Text]